πŸ‡ΊπŸ‡Έ FDA
Patent

US 7396933

Quinolinone-carboxamide compounds

granted A61PA61P1/00A61P1/04

Quick answer

US patent 7396933 (Quinolinone-carboxamide compounds) held by Theravance, Inc. expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Jul 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P1/00, A61P1/04, A61P1/10, A61P1/12